Inspire Medical Systems, Inc. INSP
Inspire Medical Systems, Inc. (NYSE: INSP) is a respiratory medical device company.
Upcoming catalysts
No catalyst is dated to the next 30 days or to an FDA action date.
Pipeline
| Program | Indication | Modality | Stage |
|---|---|---|---|
| Inspire V neurostimulation system | moderate to severe OSA | device-combination | NA_NON_THERAPEUTIC |
Recent results and decisions
- Nov 2, 2026accepted AMA CPT Editorial Panel approved new Category I CPT code for single lead hypoglossal nerve stimulation, including Inspire V, set to take effect January 1, 2028.
AMA CPT® Editorial Panel approved new Category I CPT codes for single lead hypoglossal nerve stimulation, including Inspire V, set to take effect January 1, 2028.
Filing
For subscribers
- Cash runway against each catalyst, with the company's own runway statement
- Track record: every Phase 3 readout, FDA decision and guidance slip since 2014
- Expected move for each dated catalyst, from comparable past events
- Phase 2 evidence behind each Phase 3 readout
- Companies on the same target or class
- Full catalyst list with filing sentences, deals, registered trials, Excel export
Other respiratory companies
The free Monday brief
Last week's readouts and FDA decisions and the dated catalysts in the week ahead, each with its filing sentence.